221 related articles for article (PubMed ID: 7114002)
1. Sustained-release theophylline for treatment of asthma in preschool children.
Simons FE; Luciuk GH; Simons KJ
Am J Dis Child; 1982 Sep; 136(9):790-3. PubMed ID: 7114002
[TBL] [Abstract][Full Text] [Related]
2. Effect of once daily and twice daily sustained release theophylline formulations on daytime variation of bronchial hyperresponsiveness in asthmatic patients.
Ferrari M; Olivieri M; Lampronti G; Bonazza L; Biasin C; Nacci P; Talamini G; Lo Cascio V
Thorax; 1997 Nov; 52(11):969-74. PubMed ID: 9487345
[TBL] [Abstract][Full Text] [Related]
3. Comparison of a new sustained-release theophylline preparation, TheoBeads, with Theo-Dur tablets in children with asthma.
Welch MJ; Orgel HA; Meltzer EO; Kemp JP; Gawchik S; Rooklin AR; Tinkelman DG
J Asthma; 1988; 25(5):269-74. PubMed ID: 3182591
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of serum theophylline concentrations following administration of sustained-release beads in applesauce to asthmatic preschool children.
Leeder JS; Robertson C; Correia J; Isles AF; Levison H; Macleod SM
Ann Allergy; 1986 Feb; 56(2):133-7. PubMed ID: 3946845
[TBL] [Abstract][Full Text] [Related]
5. Bioequivalence of a generic slow-release theophylline tablet in children.
Kanthawatana S; Ahrens RC; McCubbin M; Bronsky E; Blake K; Hendeles L
J Pediatr; 1994 Dec; 125(6 Pt 1):987-91. PubMed ID: 7996375
[TBL] [Abstract][Full Text] [Related]
6. Optimal time for obtaining peak and trough theophylline levels in 12-hour and 24-hour products in children.
Tinkelman DG; Lutz CN; Miller E; Cole WQ
Ann Allergy; 1987 Mar; 58(3):190-2. PubMed ID: 3826771
[TBL] [Abstract][Full Text] [Related]
7. Conversion from intravenous to sustained-release oral theophylline in pediatric patients with asthma.
Clarke DF; Werbowsky OL; Grodin MA; Shargel L
Drug Intell Clin Pharm; 1986 Sep; 20(9):700-3. PubMed ID: 3757784
[TBL] [Abstract][Full Text] [Related]
8. Sustained-release theophylline preparations in asthmatic children. A short-term comparison of two products and the relationship of serum theophylline levels and pulmonary function changes.
Rachelefsky G; Rohr A; Katz R; Wo J; Gracey V; Spector S; Siegel S; Mickey MR
Am J Dis Child; 1986 Apr; 140(4):336-40. PubMed ID: 3513540
[TBL] [Abstract][Full Text] [Related]
9. Sustained-release terbutaline vs sustained-release theophylline in young patients with asthma.
Roberts JR; Desai HI; Gillespie CA; Simons FE
Am J Dis Child; 1986 Jul; 140(7):650-4. PubMed ID: 3717101
[TBL] [Abstract][Full Text] [Related]
10. Sustained-release theophylline. Pharmacokinetic and therapeutic comparison of two preparations.
Menendez R; Kelly HW; Howick J; McWilliams BC
Am J Dis Child; 1983 May; 137(5):469-73. PubMed ID: 6846276
[TBL] [Abstract][Full Text] [Related]
11. Conversion from twice- to once-daily extended-release theophylline treatment in patients with reversible airway obstruction.
Berkowitz RB; Tinkelman DG; Marcoux JP; Rooklin AR; Zeitz HJ; Rennard SI; Moss BA; Hubbard RC; Lorber RR
J Asthma; 1995; 32(4):275-84. PubMed ID: 7629003
[TBL] [Abstract][Full Text] [Related]
12. Comparison of serum theophylline levels in asthmatic children receiving sustained-release and rapid-release theophylline tablets.
Beer S; Laver J; Benson L; Cotariu D; Neli P; Saidman JL; Viure E
Isr J Med Sci; 1982 Feb; 18(2):255-8. PubMed ID: 7068356
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic comparison of a once-daily and twice-daily theophylline delivery system.
González MA; Kisicki J; Straughn AB
Clin Ther; 1994; 16(4):686-92. PubMed ID: 7982257
[TBL] [Abstract][Full Text] [Related]
14. Comparison of a sustained-release preparation (Theo-Dur) with a conventional preparation (Nuelin) in the treatment of chronic asthma.
Haahtela T; Vilkka V; Kulstad S
Allergy; 1983 Nov; 38(8):589-92. PubMed ID: 6660438
[TBL] [Abstract][Full Text] [Related]
15. Apparent inconsistent theophylline absorption from sustained release capsules.
Uden DL; Schaber DE; Wyatt RA
Clin Pediatr (Phila); 1987 Jun; 26(6):285-7. PubMed ID: 3581636
[TBL] [Abstract][Full Text] [Related]
16. [The clinical effect of sustained-release theophylline (Theo-Dur) for asthmatic children and serum theophylline level (author's transl)].
Masaki T; Sekine H; Nagakura T; Iikura Y; Tomita Y; Asano T; Kajita T; Seo K
Arerugi; 1981 Apr; 30(4):190-6. PubMed ID: 7337549
[No Abstract] [Full Text] [Related]
17. Once-daily sustained-release theophylline reduces diurnal variation in spirometry and symptomatology in adult asthmatics.
Arkinstall WW; Atkins ME; Harrison D; Stewart JH
Am Rev Respir Dis; 1987 Feb; 135(2):316-21. PubMed ID: 3813191
[TBL] [Abstract][Full Text] [Related]
18. Comparative steady-state bioavailability of sustained-release theophylline preparations: Theo-Dur, Uni-Dur and Xanthium.
Rojanasthien N; Kovjiriyapan K; Manorot M; Pothirat C
Asian Pac J Allergy Immunol; 2001 Jun; 19(2):69-78. PubMed ID: 11699723
[TBL] [Abstract][Full Text] [Related]
19. Steady-state evaluation of twice-a-day dosing of a new sustained-release theophylline preparation for young children.
Welch MJ; Kemp JP; Orgel HA; Meltzer EO
J Asthma; 1985; 22(5):249-52. PubMed ID: 4055657
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Theolair SR and Theo-Dur tablets.
Domson JF; Hein EW; Sheen A; Sly RM
Ann Allergy; 1979 Oct; 43(4):220-2. PubMed ID: 555598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
